Follow The Filings

BLSH Bullish

Bullish earnings company data as of 4:49 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS 0.08 — —
Rev — — —
FY2026 Q2 13 Aug EPS 0.09 — —
Rev — $92.6M —

Insider trades

Open-market buys and sales by BLSH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BLSH insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $16.4M sold by 2 insiders under 10b5-1 plans
  1. Andrew Bliss Director
    Planned sale
    $4,010 100 shares at $40.10 <0.1% of stake
    Traded Sep 24 Filed Sep 28
  2. Andrew Bliss Director
    Planned sale
    $9.9M 245,129 shares at $40.46 4.9% of stake
    Traded Sep 21–23 Filed Sep 23
  3. Thomas W Farley CEO
    Planned sale
    $3.5M 80,000 shares at $43.95 100% of stake
    Traded May 11 Filed May 13
  4. Thomas W Farley CEO
    Sale
    — 494 shares <0.1% of stake
    Traded May 5 Filed May 6
  5. Thomas W Farley CEO
    Planned sale
    $2.9M 80,000 shares at $36.41 1.6% of stake
    Traded Apr 10 Filed Apr 13

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants, 2 other transactions, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G/A —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
20-F FORM 20-F
6-K FORM 6-K
SCHEDULE 13D/A —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.